Defunct Company
Total Trials
11
As Lead Sponsor
2
As Collaborator
9
Total Enrollment
4,994
NCT01777217
VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate
Phase: Phase 4
Role: Lead Sponsor
Start: Feb 28, 2013
Completion: Jan 31, 2014
NCT02851498
Use of Novel High-protein Food Products To Reduce Insulin Resistance
Phase: N/A
Role: Collaborator
Start: Jan 31, 2015
Completion: Sep 30, 2016
NCT04217863
To Observe the Psychophysiological Alterations in Traumatic Stress Subjects
Start: Dec 2, 2019
Completion: Aug 10, 2021
NCT04222504
Community-based Venues for Delivery of Healthcare Services: Proof of Concept Pilot
Start: Feb 8, 2021
Completion: Dec 31, 2025
NCT05038774
Educational Intervention for Hypertension Management
Start: Sep 30, 2021
Completion: Dec 31, 2022
NCT05186649
Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis
Start: Dec 1, 2021
Completion: Jul 15, 2022
NCT05508919
Effect of Biofeedback Training to Reduce Anxiety
Start: Oct 31, 2022
Completion: May 31, 2023
NCT06316453
Prospective Assessment of Atherosclerotic Cardiovascular Disease (ASCVD) Risk
Start: Jan 1, 2024
Completion: Dec 31, 2024
NCT06910982
Yoga and Mindfulness for Chronic Low Back Pain: A Randomized Controlled Trial
Start: Apr 1, 2025
Completion: Jun 30, 2027
NCT06960330
Wearable Biofeedback Devices for Remote Physiotherapy and Rehabilitation
Start: May 6, 2025
Completion: Feb 1, 2028
NCT07205042
Walking for Hypothyroidism Trial (WHT)
Start: Nov 1, 2025
Completion: Jun 30, 2026